1. ABCB1 Polymorphism Is Associated with Higher Carbamazepine Clearance in Children
- Author
-
Natasa Djordjevic, Jelena Cukic, Dragana Dragas Milovanovic, Marija Radovanovic, Ivan Radosavljevic, Jelena Vuckovic Filipovic, Slobodan Obradovic, Dejan Baskic, Jasmina R. Milovanovic, Slobodan Jankovic, and Dragan Milovanovic
- Subjects
ABCB1 ,genetic polymorphism ,carbamazepine ,population pharmacokinetics ,children ,Medicine ,Pediatrics ,RJ1-570 - Abstract
The aim of our study was to investigate the role of ABCB1 polymorphism in the pharmacokinetics of carbamazepine (CBZ) in children. The study enrolled 47 Serbian pediatric epileptic patients on CBZ treatment. Genotyping for ABCB1 1236CABCB1 1236CABCB1 + 0.0176 × CYP1A2 + 0.000151 × DD where SEX has a value of 1 if male and 0 if female, ABCB1 has a value of 1 if C-G-C/T-T-T and 0 if any other ABCB1 diplotype, CYP1A2 has a value of 1 if −163A/A and 0 if −163C/C or C/A, and DD is the total CBZ daily dose (mg/day). The presence of the ABCB1 1236T-2677T-3435T haplotype is associated with an increased clearance of CBZ in pediatric epileptic patients.
- Published
- 2025
- Full Text
- View/download PDF